Bare Metal Stent

A vascular metal mesh tube without a coating.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
BACKGROUND Sustained benefits of drug-eluting stents in femoropopliteal arteries have not been demonstrated. This prospective… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Primary results of the HORIZONS-AMI trial have been previously reported. In this final report, we aimed to assess 3… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Drug-eluting stents compared with bare metal stents (BMS) may increase late stent thrombosis (ST), although an… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Sirolimus-eluting stents markedly reduce the risk of restenosis compared with bare metal stents. However, it is not… (More)
  • table 1
  • table 2
  • table 3
  • table 5
  • table 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
CONTEXT Compared with bare metal stents, drug-eluting stents reduce restenosis in noncomplex lesions. The utility of drug-eluting… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVES This study was designed to compare the clinical and angiographic outcomes of sirolimus-eluting stent (SES) and bare… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND The safety and efficacy of percutaneous coronary intervention in unprotected left main (ULM) coronary arteries are… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVES We assessed the safety and effectiveness of the sirolimus-eluting stent (SES) in treating single de novo long lesions… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Randomized clinical trials have shown that a sirolimus-eluting stent significantly reduces restenosis after… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Early clinical studies demonstrated the feasibility of local paclitaxel delivery in reducing restenosis after… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?